|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Robotic Probes for Minimally Invasive Cardiac and Gastrointestinal Surgery |
 |
| Management |
| David W. Wagner, Founding CEO and Executive Chairman; Samuel F. Straface, Ph.D., President & CEO; Howie Choset, Ph.D, Chief Technology Officer & Co-Founder; Marco A. Zenati, M.D., Chairman, Scientific Advisory Board & Co-Founder; Richard (Dick) L. Buckingham, Chief Financial Officer, Director; Kevin P. Gilmartin, Vice President Product Developement |
| |
|
|
| |
|
| Keywords |
| Cardiology, Gastroenterology, Orthopedics Surgery, Cardiac Surgery, Electrophysiology, Colonoscopy, Laparoscopy, Arthroscopy |
|
|
|
| Description |
|
Cardiorobotics, Inc. is developing advanced robotic technologies for use in a wide range of applications, including: medical, industrial, military, and law enforcement. The company's highly articulated robotic probes have unlimited degrees of freedom, are tele-operated, and are able to steer a self-supported, non-linear path. |
 |
| Products / Services |
The company's Articulated Robotic MedProbe (ARM) product line includes: the cardioARM for minimally-invasive cardiac surgery (MICS) and the laparoARM, gastroARM and arthroARM for various endoscopic and laparoscopic procedures.
|
 |
| Technology / Differentiation |
| The central element of Cardiorobotics' technology is a teleoperated probe consisting of a series of links. The probe is highly flexible and thus either assumes the shape of its surroundings or can be reshaped. The probe 'remembers' its previous configurations as it moves through a three-dimensional volume. The links of the probe can be made out of almost any material, including plastic, allowing it to be 'disposable'. A working channel or lumen, allows tools to pass through the probe and perform various procedures. |
 |
| Market / Customers |
Within the medical field, the company plans to serve a number of different specialist areas, including: minimally-invasive cardiac surgery, electrophysiology, laparoscopy, colonoscopy, and arthroscopy.
|
 |
| Status |
| Cardiorobotics plans to commence human clinical trials in 2009. |
 |
|
|
|
|
|
|